The antitrust landscape has evolved at lightning speed in recent years, raising new challenges as businesses contend with sweeping changes to the economy, growing international operations, and aggressive enforcement in global markets.
We bring a trial lawyer’s perspective to the defense and prosecution of high-stakes antitrust matters, with an outstanding record of success both at trial and on appeal. Our lawyers have successfully represented clients in civil antitrust cases involving monopolization, price fixing, and other claims in numerous industries, including the technology, pharmaceutical, and medical device industries. We also have a wealth of experience representing corporations and individuals in criminal investigations by the Antitrust Division of the U.S. Department of Justice.
Because we represent both defendants and plaintiffs, we offer a targeted, strategic approach to clients in both areas. Our success is based on our ability to cut through the clutter, identifying and communicating the core issues that will enable our clients to prevail at trial.
Our work has been recognized by a wide range of publications and rankings organizations, including Benchmark Litigation, Law360, and The Best Lawyers in America. Chambers USA describes us as “hard-driving, insightful, and aggressive,” with “an energy that is tremendous.”
Represented a leading mobile handset manufacturer regarding price-fixing antitrust claims under U.S. and international laws against manufacturers of lithium-ion batteries worldwide.
GlaxoSmithKline v. Abbott Laboratories. Represented Glaxo in a high-profile antitrust, unfair competition, and breach of contract action against Abbott Laboratories, alleging Abbott abused its market dominance and engaged in predatory pricing of HIV drugs. Settled on favorable grounds for the client.
Represented a Fortune 100 telecommunications company in assessing claims against manufacturers of LED and LCD parts used by the telecommunications company.
Represented a leading information technology manufacturer regarding antitrust and breach of contract claims against a major supplier.
Masimo Corp. v. Mindray DS USA Inc. Defended Masimo Corp., a leading global medical technology company, in cases in the U.S. and China against claims of monopolization of the pulse oximeter monitor market, conspiracy to monopolize, group boycott, agreement in restraint of trade, Walker Process monopolization, and tying.
United States v. DIRECTV Group Holdings LLC and AT&T Inc. Represented a former AT&T executive in antitrust case brought by the U.S. Department of Justice against DIRECTV and AT&T for alleged unlawful information sharing in connection with negotiations to telecast Dodgers games in the Los Angeles area.
United States v. Anthem et al.; United States v. Aetna et al. Represented a global professional services company in connection with the Department of Justice Antitrust Division’s investigation of the proposed mergers of Anthem with Cigna and Aetna with Humana, and represented the company in the federal litigation brought by the Department of Justice.
United States v. Sabry Lee (USA) Inc. Represented Sabry Lee, an auto lights distributor, in an antitrust case brought by the U.S. Department of Justice alleging a conspiracy to fix prices of aftermarket auto lights.
Represented Chef’s Choice Mesquite Charcoal, a leading distributor and seller of charcoal throughout the U.S., in an antitrust case brought by the U.S. Department of Justice alleging conspiracy to refrain from competing for the sale of charcoal.
WGA v. UTA, et al. Represented United Talent Agency in a matter involving allegations of conspiracy to fix prices in the market for television and motion picture “packaging fees” in violation of the Sherman Act and Cartwright Act and unlawful group boycott.
Estate of Garrison v. Warner Bros. Represented Warner Bros. in a matter involving allegations that the major studios, networks, and talent agencies conspired to fix prices by agreeing to a standardized “net profits” definition for profit participants.
Intel v. Fortress Investment Group Represented Fortress in a matter involving allegations that Fortress, a unit of SoftBank Group Corp., violated federal antitrust law through an illegal “patent aggregation scheme”.